Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

February 14, 2026 updated by: Waheed Fawzy Abdelrasol, New Valley University

Investigating the Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

This study aimed to investigate the association between meatal stenosis and primary nocturnal enuresis severity, and evaluated therapeutic outcomes following surgical correction.

Study Overview

Detailed Description

Primary nocturnal enuresis (PNE) is a prevalent pediatric condition characterized by involuntary urination during sleep in children aged five years or older who have never achieved consistent nighttime dryness. The prevalence of PNE decreases with age, affecting approximately 15% of five-year-old and decreasing to 1-2% by adolescence.

Meatal stenosis, defined as the pathological narrowing of the urethral meatus, is an underexplored potential factor. This condition is known to cause obstructed urinary flow, incomplete bladder emptying, and increased bladder pressure, all of which may contribute to enuresis.

The incidence of meatal stenosis is higher in circumcised males but can also occur in uncircumcised males and females due to inflammation, trauma, or infection

Study Type

Observational

Enrollment (Actual)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo Governorate
      • New Valley, Cairo Governorate, Egypt, 72511
        • New Valley University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This retrospective study population includes male children aged 7-12 years who presented with primary nocturnal enuresis at a pediatric urology clinic between October 2022 and December 2024.

Description

Inclusion Criteria:

  • Male children aged 7-12 years.
  • Diagnosed with primary nocturnal enuresis.
  • Evaluated and treated at the study center between January 2021 and December 2024.
  • Confirmed diagnosis of meatal stenosis based on clinical examination and uroflowmetry when indicated.
  • Patients who underwent meatoplasty and completed the prescribed follow-up period.

Exclusion Criteria:

  • Secondary enuresis (previously dry for ≥ 6 months before recurrence of bedwetting).
  • Known neurological disorders (e.g., spina bifida, cerebral palsy) or developmental delays.
  • Structural anomalies of the urinary tract other than meatal stenosis (e.g., posterior urethral valves, vesicoureteral reflux).
  • Children who did not complete the follow-up or had incomplete clinical records.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group
Patients who underwent meatoplasty.
Patients diagnosed with primary nocturnal enuresis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between Meatal Stenosis and primary nocturnal enuresis
Time Frame: 3 years from collecting the data from the database
Association between Meatal Stenosis and primary nocturnal enuresis was assessed to determine whether there is a significant relationship between the presence of meatal stenosis and the occurrence of primary nocturnal enuresis in male children aged 7-12 years.
3 years from collecting the data from the database

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resolution of primary nocturnal enuresis post-meatoplasty
Time Frame: 3 years from collecting the data from the database
Resolution of primary nocturnal enuresis post-meatoplasty was assessed to assess the effectiveness of meatoplasty in resolving primary nocturnal enuresis in children with meatal stenosis.
3 years from collecting the data from the database
Need for Revision Meatoplasty
Time Frame: 3 years from collecting the data from the database
Need for Revision Meatoplasty was assessed in patients due to persistent or recurrent meatal stenosis after the initial surgery.
3 years from collecting the data from the database
Prevalence of Meatal Stenosis in primary nocturnal enuresis patients
Time Frame: 3 years from collecting the data from the database
Prevalence of Meatal Stenosis in primary nocturnal enuresis patients was assessed among children diagnosed with primary nocturnal enuresis within the study period (2021-2024).
3 years from collecting the data from the database
Incidence of complications
Time Frame: 3 years from collecting the data from the database
Any complications or adverse events following meatoplasty, including infection, scarring, or urinary retention were recorded.
3 years from collecting the data from the database

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2021

Primary Completion (Actual)

March 10, 2025

Study Completion (Actual)

March 10, 2025

Study Registration Dates

First Submitted

February 14, 2026

First Submitted That Met QC Criteria

February 14, 2026

First Posted (Actual)

February 20, 2026

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 14, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2025130002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

IPD Sharing Time Frame

The data will be available upon a reasonable request from the corresponding author.

IPD Sharing Access Criteria

After the end of study for one year.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Clinical Trials on Meatoplasty Primary nocturnal enuresis.

Subscribe